-
Genomic characterization of metastatic breast cancers
Study
EGAS00001003290
-
Germline TP53 mutations undergo copy number gain years prior to tumor diagnosis
Study
EGAS00001005982
-
RNA sequencing of undifferentiated sarcomas
Study
EGAS00001003291
-
Res1_HT29_exp2_MC_03_03_22
Study
EGAS00001006093
-
Whole genome sequencing of tumour and matched normal from patients with family history of breast cancer
Study
EGAS00001003305
-
Multimodal immunogenomic biomarker analysis of tumors from pediatric patients enrolled to a phase 1-2 study of single-agent atezolizumab
Study
EGAS00001006004
-
Res1_H23_exp1_MC_04_03_22
Study
EGAS00001006091
-
Spatio-temporal analysis of prostate tumors in situ suggests pre-existence of treatment-resistant clones
Study
EGAS00001006113
-
A Proteogenomic Analysis of Clear Cell Renal Cell Carcinoma in a Chinese Population
Study
EGAS00001006005
-
Non-small cell lung cancer proteome subtypes expose targetable oncogenic drivers and immune evasion mechanisms
Study
EGAS00001005482
-
Novel mutations in TOP2A in gliomas
Study
EGAS00001004556
-
Cancer and germline exomes, and cancer RNA-seq consisiting of FASTQ paired-end reads from melanoma, lung and colon cancer samples
Study
EGAS00001005513
-
Whole genome sequencing of colorectal cancer patients (SG-BULK-1)
Study
EGAS00001006030
-
Genomewide copy number alteration screening of circulating plasma DNA
Study
EGAS00001006031
-
Spatial atlas of clonal copy number alterations in co-existing benign and malignant tissue
Study
EGAS00001006124
-
MutWP5__CRUK_Mutographs_of_Cancer__Breast__Cancer_Mastectomy__WG_
Study
EGAS00001003317
-
Exome sequencing of paired primary tumor and metastatic breast cancer
Study
EGAS00001004578
-
Dedifferentiated_Melanoma
Study
EGAS00001003471
-
Functional screening on patient-derived organoids identifies a therapeutic bispecific antibody that triggers EGFR degradation in LGR5+ tumor cells
Study
EGAS00001004584
-
Understanding_the_multicellular_dynamics_of_clear_cell_renal_cell_carcinoma___visium
Study
EGAS00001006045
-
Patient-tailored design for selective co-inhibition of leukemic cell subpopulations
Study
EGAS00001004614
-
WGS of gastric cancer in the Japanese population (81 gastric cancers of NCC)
Study
EGAS00001006051
-
Germline variants in patients with rare cancers and their implications for precision cancer medicine: experiences from the Multicenter MASTER Trial by the German Cancer Consortium (HIPO_021)
Study
EGAS00001005537
-
Hepatitis B virus integrations promote local and distant oncogenic driver alterations in hepatocarcinogenesis
Study
EGAS00001004629
-
Targeted sequencing of breast cancer susceptibility genes for 1,995 Japanese breast cancer patients
Study
EGAS00001004630